Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05511844
Title Study of ORM-5029 in Subjects With HER2-Expressing Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Orum Therapeutics USA, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Alabama Birmingham Birmingham Alabama 35233 United States Details
University of California - Los Angeles Los Angeles California 90095 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Weill Cornell Medicine-New York New York New York 10065 United States Details
Sarah Cannon Research Institute at Tennessee Oncology Nashville Tennessee 32703 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
NEXT Oncology San Antonio Texas 78229 United States Details
NEXT Oncology - Virginia Cancer Specialists Fairfax Virginia 22031 United States Details
Fred Hutchinson Cancer Center Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field